Korro Bio

Korro Bio is a Massachusetts-based RNA editing company that develops and commercializes novel genetic medicines for the treatment of liver, eye and CNS disorders.

Business Model:

Revenue: $5M

Employees: 51-200

Detailed Korro Bio Information

Geographic Data

Korro Bio headquarters map

Address: One Kendall Square

City: Cambridge

State: MA

Zip: 02139

Country: US

Financial Info

Stage:

series b

Raised Last:

$116M

Raised Total:

$208M

Metrics

2,770,243Website Global Rank

6,209Website Monthly Traffic

Twitter Followers

Description

Korro Bio is a Massachusetts-based RNA editing company that develops and commercializes novel genetic medicines for the treatment of liver, eye and CNS disorders.

Contact Phone:
+18572012700

Contact Email:

Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
1/2022 Series B $0 Alexandria Venture Investments
Atlas Venture
Cormorant Asset Management
Eventide
Fidelity Management and Research Company
Invus
Ischyros New York
Monashee Investment Management
MP Healthcare Venture Management
New Enterprise Associates
Point72
Qiming Venture Partners USA
Sixty Degree Capital
Surveyor Capital
Verition Fund Management
Wu Capital
Alexandria Venture Investments
Atlas Venture
Cormorant Asset Management
Eventide
Fidelity Management and Research Company
Invus
Ischyros New York
Monashee Investment Management
MP Healthcare Venture Management
New Enterprise Associates
Point72
Qiming Venture Partners USA
Sixty Degree Capital
Surveyor Capital
Verition Fund Management
Wu Capital
5/2019 Seed $4M Atlas Venture
9/2020 Series A $0 Alexandria Venture Investments
Atlas Venture
Cormorant Asset Management
MP Healthcare Venture Management
New Enterprise Associates
Qiming Venture Partners USA
Surveyor Capital
Wu Capital
Alexandria Venture Investments
Atlas Venture
Cormorant Asset Management
MP Healthcare Venture Management
New Enterprise Associates
Qiming Venture Partners USA
Surveyor Capital
Wu Capital
1/2018 Seed Round 2 - Atlas Venture
New Enterprise Associates
Atlas Venture
New Enterprise Associates
1/2022 Series B 16 $116M Eventide Asset Management
Fidelity Management & Research Company LLC
Invus
Point72
Verition Fund Management
Monashee Investment Management
Sixty Degree Capital
Atlas Venture
New Enterprise Associates
Wu Capital
Qiming Venture Partners USA
Surveyor Capital
Cormorant Asset Management
MP Healthcare Venture Management
Alexandria Venture Investments
Atlas Venture
Cormorant Asset Management
Eventide
Fidelity Management and Research Company
Invus
Ischyros New York
Monashee Investment Management
MP Healthcare Venture Management
New Enterprise Associates
Point72
Qiming Venture Partners USA
Sixty Degree Capital
Surveyor Capital
Verition Fund Management
Wu Capital
9/2020 Series A 8 $91.5M Wu Capital
Atlas Venture
New Enterprise Associates
Qiming Venture Partners USA
Surveyor Capital
MP Healthcare Venture Management
Alexandria Venture Investments
Alexandria Venture Investments
Atlas Venture
Cormorant Asset Management
MP Healthcare Venture Management
New Enterprise Associates
Qiming Venture Partners USA
Surveyor Capital
Wu Capital
1/2018 Seed Round 2 - Atlas Venture
New Enterprise Associates
Atlas Venture
New Enterprise Associates
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research